comprehensive -WSS

comprehensive

author：hotspot 2025-09-06 03:38:54 - browse：1

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Prime Medicine says its gene editing passes test in monkeys

hotspot

WSS

Infant mortality in U.S. rose last year for first time in decades: CDC

How to convince healthy people to buy insurance

Live blog: Hearing on CRISPR

After Sarepta trial failure, Duchenne families brace for more debate

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

What is microchimerism and how does it affect maternal health?

focus

comprehensive

Sign up for D.C. Diagnosis

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Humans aren't the only ones with an imagination. Rats have it too

Jerome Adams on the need for new antivirals for Covid

What is microchimerism and how does it affect maternal health?

BioMarin wins approval for gene therapy to treat hemophilia A

All of Us, NIH's precision medicine initiative, gets a big boost

In Memoriam: Notable people who died in 2023

Prime Medicine says its gene editing passes test in monkeys

Sports medicine is finally prioritizing gender equality

Why 40% Americans with Parkinson’s don’t see a neurologist

entertainment

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Prime Medicine says its gene editing passes test in monkeys

Infant mortality in U.S. rose last year for first time in decades: CDC

Living with Fabry disease, a condition that causes chronic pain

Infant mortality in U.S. rose last year for first time in decades: CDC

Why 40% Americans with Parkinson’s don’t see a neurologist

Wikipedia

hotspot

hotspot

focus